Fig. 1.

NGR1 administration improves neurological function after SCI. BBB scores of the Sham + vehicle, Sham + NGR1, SCI + vehicle, and SCI+NGR1 groups were examined at 1, 3, 7, 14, and 21 days after SCI. N = 6. Data are represented as mean ± SEM. Repeated-measures analysis of variance (ANOVA) followed by Bonferroni’s multiple comparisons posttest was used. *P < 0.05 vs. the Sham + vehicle group; ^#P < 0.01, ^###P < 0.001 vs. the SCI + vehicle group. BBB, Basso-Beattie-Bresnahan; NGR1, notoginsenoside R1; SCI, spinal cord injury.